Top

Published in:

01-09-2011 | Review Article

Cellular kinetics of neuroblastoma and the role of surgery

Author: Tatsuo Kuroda

Published in: Pediatric Surgery International | Issue 9/2011

Abstract

Neuroblastoma is known for its peculiar cellular kinetics, which has provoked some controversy regarding surgical treatment. Highly sensitive exploration systems using reverse transcription polymerase chain reaction (RT-PCR) methods have been developed to detect neuroblastoma cells. In our series of 49 patients with advanced neuroblastoma, circulating tumor cells (CTC) were detected by this system in 55.6% of the stage 4 patients who were examined, suggesting that the primary lesion may release tumor cells into the peripheral blood. The Kaplan–Meier survival rate was significantly lower among the patients with CTC or chemotherapy-insensitive bone marrow micrometastasis, compared with those without detectable micrometastasis (33.8 vs. 87.5%, P < 0.05). In contrast, a stage 3 patient with MYCN amplification exhibited drastic local relapse without systemic dissemination of the disease. Two patients were positive for CTC without an identifiable primary site. These observations indicate that the local growth of the primary tumor and tumor cell dissemination may be regulated by different molecular mechanisms in neuroblastomas. MYCN amplification seemed to be more closely associated with localized tumor growth but was minimally correlated with CTC positivity. High-risk neuroblastoma may include two separate subgroups characterized by different cellular kinetics: a local risk cohort and a systemic risk cohort. Surgical strategies for neuroblastoma should be determined with taking this cellular kinetics into consideration.

Evans AE, Chatten J, D’Angio GJ et al (1980) A review of 17 IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer 45:833–839PubMedCrossRef

Nakagawara A (2001) Trk receptor tyrosine kinases: a bridge between cancer and neuronal development. Cancer Lett 169:107–114PubMedCrossRef

Kuroda T, Honna T, Morikawa N et al (2005) Tumor cell dynamics and metastasis in advanced neuroblastoma. Pediatr Surg Int 21:859–863PubMedCrossRef

Coustan-Smith E et al (1993) N-CAM(CD56) expression by CD34+ malignant myeloblasts has implication for minimal residual disease detection in acute myeloid leukemia. Leukemia 7:853PubMed

Dworzak MN et al (2002) Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 99:1952PubMedCrossRef

McKenna RW et al (2001) Immunophenotypic analysis of hematogenes (B-lyphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 98:2498PubMedCrossRef

Moss TJ, Reynolds CP, Sather HN et al (1991) Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219–226PubMedCrossRef

Cheung IY, Barber D, Cheung NK (1998) Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers. Clin Cancer Res 4:2801–2805PubMed

Cheung IY, Cheung NK (2001) Quantification of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Clin Cancer Res 7:1698–1705PubMed

10.

Pession A, Libri V, Sartini R et al (2003) Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma. Oncol Rep 10:357–362PubMed

11.

Viprey VF, Corrias MV, Kagedal B et al (2007) Standardization of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 43:341–350PubMedCrossRef

12.

Mattano LA Jr, Moss TJ, Emerson SG (1992) Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52:4701–4705PubMed

13.

Helfrich W, ten Poele R, Meersma GJ et al (1997) A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood. Br J Cancer 76:29–35PubMedCrossRef

14.

Burchill SA, Bradbury FM, Smith B et al (1994) Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer 57:671–675PubMedCrossRef

15.

Lambooy LH, Gidding CE, van den Heuvel LP et al (2003) Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma. Clin Cancer Res 9:812–819PubMed

16.

Kuroda T, Saeki M, Mizutani S et al (1997) Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction. J Pediatr Surg 32:69–72PubMedCrossRef

17.

Miyajima Y, Kato K, Numata S et al (1995) Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 75:2757–2761PubMedCrossRef

18.

Wang Y, Einhorn P, Triche TJ et al (2000) Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors. Clin Cancer Res 6:551–558PubMed

19.

Gilbert J, Norris MD, Marshall GM et al (1997) Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma. Br J Cancer 75:1779–1781PubMedCrossRef

20.

Cheung IY, Lo Piccolo MS, Kushner BH et al (2003) Quantification of GD2 synthetase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma. J Clin Oncol 21:1087–1093PubMedCrossRef

21.

Olta S, Martinez F, Orellana C et al (2004) Minimal residual disease in neuroblastoma: to GAGE or not to GAGE. Oncol Res 14:291–295

22.

Cheung IY, Feng Y, Vickers A et al (2007) Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. J Mol Diagn 9:237–241PubMedCrossRef

23.

Schweisguth O (1979) Tumeur dela crete neurale. In: Scweisguth O(ed) Tumeurs solides del’enfant, Flammarion, Paris, pp 165

24.

Kobayashi K, Kaneda N, Ichinose H et al (1988) Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem 103:907–912PubMed

25.

O’Malley KL, Anhalt MJ, Martin BM et al (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5’- alternative splice sites responsible for multiple mRNAs. Biochemistry 26:2910–2914

26.

Grima B, Lamouroux A, Boni C et al (1987) A single human gene encoding multiple tyrosine hydroxylase with different predicted functional characteristics. Nature 326:707–711PubMedCrossRef

27.

Naito H, Kuzumaki N, Uchino J et al (1991) Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762–765PubMedCrossRef

28.

Rininsland F, Hahn A, Niemann-Seyde S et al (1992) Identification of a new DMD gene deletion by ectopic transcript analysis. J Med Genet 29:647–651PubMedCrossRef

29.

Kuroda T, Morikawa N, Matsuoka K et al (2008) Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma. J Pediatr Surg 43:2182–2185PubMedCrossRef

30.

Castleberry RR, Pritchard J, Ambros P et al (1997) The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer 33:2113–2116PubMedCrossRef

31.

Fukuda M, Miyajima Y, Miyashita Y et al (2001) Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study. J Pediatr Hematol Oncol 23:10–13PubMedCrossRef

32.

Hansford LM, McKee AE, Zhang L et al (2007) Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67:11234–11243PubMedCrossRef

33.

Monclair T, Brodeur GM, Ambros PF et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303PubMedCrossRef

34.

McGregor LM, Rao BN, Davidoff AM et al (2005) The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease. Cancer 104:2837–2846PubMedCrossRef

35.

Kuroda T, Saeki M, Honna T, Masaki H, Tsunematsu Y (2003) Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma; does it really make sense? J Pediatr Surg 38:1735–1738PubMedCrossRef

36.

Shorter NA, Davidoff AM, Evance AE et al (1995) The role of surgery in the management of stage IV neuroblastoma: a single institution study. Med Pediatr Oncol 24:287–291PubMedCrossRef

37.

La Quaglia MP, Kushner BH, Heller G et al (1994) Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 29:1162–1165PubMedCrossRef

38.

Hashii Y, Kusafuka T, Ohta H et al (2008) A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy. Pediatr Hematol Oncol 25:439–450PubMedCrossRef

39.

Canete A, Jovani C, Lopez A et al (1998) Surgical treatment for neuroblastoma: complications during 15 years’ experience. J Pediatr Surg 33:1526–1530PubMedCrossRef

40.

Kaneko M, Ohkawa H, Iwanaka M (1997) Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg 32:1616–1619PubMedCrossRef

41.

Kuroda T, Saeki M, Honna T et al (2006) Late complications after surgery in Patients with neuroblastoma. J Pediatr Surg 41:2037–2040PubMedCrossRef

Title: Cellular kinetics of neuroblastoma and the role of surgery
Author: Tatsuo Kuroda
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Pediatric Surgery International / Issue 9/2011
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI: https://doi.org/10.1007/s00383-011-2949-6

2024 ASCO Annual Meeting

Springer Medicine

Cellular kinetics of neuroblastoma and the role of surgery

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2011

Systematic review for paediatric metachronous contralateral inguinal hernia: a decreasing concern

Papillary thyroid carcinoma does not have standard course in children

The cholinergic response is increased in isolated ileum from gastroschisis rat model

Patch repair is an independent predictor of morbidity and mortality in congenital diaphragmatic hernia

Issues in the management of simple and complex meconium ileus

Non-hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer center